AKT1 and liver cancer: In the BEL-7404 liver cancer cell line, pretreatment with the Akt agonist SC-79 and the apoptosis-targeting Caspase inhibitor Z-VAD-FMK for 1 h followed by PL treatment for 24 h upregulated p-Akt expression.